Two series of N′-(E)-heteroaromatic-isonicotinohydrazide derivatives (3a-f and 4a-b) and 1-(7-chloroquinolin-4-yl)-2-[(heteroaromatic)methylene] hydrazone derivatives (5a-f and 6a-b) have been synthesized and evaluated for their in vitro antibacterial activity against Mycobacterium tuberculosis H 37Rv. Several compounds were noncytotoxic and exhibited significant minimum inhibitory concentration (MIC) activity (3.12, 2.50, 1.25, or 0.60 μg/mL), which can be compared to that of the first-line drugs ethambutol (3.12 μg/mL) and rifampicin (2.0 μg/ml). These results can be considered an important starting point for the rational design of new leads for anti-TB compounds. ©2010 with author.
CITATION STYLE
Ferreira, M. D. L., Gonçalves, R. S. B., Cardoso, L. N. D. F., Kaiser, C. R., Candéa, A. L. P., Henriques, M. D. G. M. D. O., … De Souza, M. V. N. (2010). Synthesis and antitubercular activity of heteroaromatic isonicotinoyl and 7-chloro-4-quinolinyl hydrazone derivatives. TheScientificWorldJournal, 10, 1347–1355. https://doi.org/10.1100/tsw.2010.124
Mendeley helps you to discover research relevant for your work.